Who we are What we do Steering committee Operating team Trialists Former contributors
Mapping Research delay Treatments tested Networks Research gaps Treatment mapping
Pharmacologic treatments Nonpharmacologic treatments Long COVID treatments Preventive interventions
Living mapping Living evidence synthesis
☰

The COVID-NMA initiative
A living mapping and living systematic review of Covid-19 trials

COVID-NMA is an international research initiative supported by the WHO and Cochrane.

We provide a living mapping of COVID-19 trials available through interactive data visualizations. We are also conducting living evidence synthesis on preventive interventions, treatments and vaccines for COVID-19 to assist decision makers.

See the description of our model here and our living review protocol here.

LIVING MAPPING OF TRIALS

(i.e., trials registered on the WHO platform)
Updated weekly

1977
Randomized Trials
1131 RCTs recruiting

1624
RCTs on treatments
(940 recruiting)

281
RCTs on prevention
(146 recruiting)

72
RCTs on vaccines
(45 recruiting)

LIVING SYNTHESIS OF PUBLISHED TRIALS

(include both articles and preprints)
Updated daily

93
RCTs with results
included in our evidence synthesis

85
RCTs on treatments

7
RCTs on prevention

1
RCTs on vaccines

Weekly update

Weekly update: October 12, 2020 to October 16, 2020, 2020

Newsletter

To receive updates on our project and research findings, please subscribe to our digest, we will share with you new RCT results and other interesting news.

This work received some funding from the Agence Nationale de la Recherche (ANR), the World Health Organization (WHO), Cochrane France, Center of Research in Epidemiology and StatisticS (CRESS), Centre d’Epidémiologie Clinique (GHU Cochin, Hôtel Dieu, Assistance Publique Hôpitaux de Paris (APHP) and Université de Paris), Centre national de la recherche scientifique (CNRS) and the Federal Ministry of Health, Germany